Frequently asked questions
Is the Hazelden Co-occurring Disorders Program evidence-based?
The Hazelden Co-occurring Disorders Program is based on findings, observations, and studies of more than two hundred addiction treatment programs using the Dual Diagnosis Capability in Addiction Treatment (DDCAT) Index. The DDCAT was developed as a benchmark measure to assess the capacity of an addiction treatment program. The benchmarks are based on expert consensus and evidence-based services for persons with co-occurring disorders.
Drawing upon the numerous randomized controlled trials testing the Integrated Dual Disorder Treatment (IDDT) model, as well as the rapidly accumulating evidence base for practices with co-occurring substance use and non-severe disorders, the Hazelden Co-occurring Disorders Program represents the state-of-the-science in treatment approaches for persons in addiction treatment settings.
Since the evidence base for co-occurring disorders in addiction treatment exists on a continuum, each component of the program describes the scientific status of the various treatment approaches, from investigative to promising to established practices. In some components -- for example, the Family Program -- careful adaptations of evidence-based approaches are made in order to be relevant for patients with non-severe psychiatric disorders in addiction treatment programs.
How is the Hazelden Co-occurring Disorders Program different from other programs?
The Hazelden Co-occurring Disorders Program is specifically designed as an effective treatment program for patients with non-severe co-occurring disorders. The interventions in this program are evidence-based and primarily drawn from current research and practice in motivational interviewing, cognitive-behavioral therapy, and Twelve Step facilitation.
This program is a comprehensive guide for clinicians, but also includes all the support tools necessary to implement an integrated treatment program to fulfill the needs of patients, family members, team members, and other stakeholders. In addition to four separate clinician's guides, these support tools include the Clinical Administrator's Guidebook (a program assessment guide), Medication Management for clinicians and medical directors, and A Guide for Living with Co-occurring Disorders (a 90-minute DVD for clinicians, patients, and family members).
Who can use the Hazelden Co-occurring Disorders Program?
The seven components of the Hazelden Co-occurring Disorders Program are designed to be used by agency directors, administrators, supervisors, and clinicians. The program is designed for use with adult patients, as well as their family members, who are participating in a residential or outpatient treatment and/or mental health program for substance use and non-severe mental health disorders. These materials have been developed within the context of addiction treatment programs, but are equally useful when applied in a mental health program that would like to offer integrated treatment for co-occurring disorders.
Hard copies of handouts for patients (or forms for clinicians) are included in the three-ring binder for each curriculum. Reproducible copies of these handouts or forms are also available on the CD-ROM included with each curriculum. The Hazelden Co-occurring Disorders Program is suitable for individual or group therapy. Family members, friends, and other loved ones of patients are encouraged to participate in this program. Research shows that when family members are involved in the program, recovery for the patient is more likely.
Is the Hazelden Co-occurring Disorders Program compatible with Twelve Step recovery?
For the program to be consistent with principles set forth in Alcoholics Anonymous (AA), Narcotics Anonymous (NA), and other recovery fellowships, the clinician should advocate and support the idea that the patient's best interest is for abstinence from all mood-altering substances, including alcohol, drugs, and any pharmaceuticals that the patient may be taking without a prescription.
Patients are also encouraged to attend other peer recovery support groups, such as Dual Recovery Anonymous (DRA) or Double Trouble in Recovery (DTR). It is also recommended that patients in this program purchase or be allowed to borrow copies of AA or NA publications. Furthermore, Twelve Step facilitation is covered in Curriculum 2: Integrating Combined Therapies, as one of the three recommended evidence-based addiction treatment models.
What special issues might arise when dealing with different cultural groups?
The use of the Hazelden Co-occurring Disorders Program interventions is not limited to certain races, ethnicities, or cultures. The educational information and inspirational stories included in the program guides and in the program DVD depict and honor individual and cultural diversity.
This aspect of the Hazelden Co-occurring Disorders Program makes it very appealing to people in many cultures. The delivery of information can be tailored to a particular population to make it as culturally specific as desired. The use of illustrations that depict diversity helps make the material more acceptable by a wide range of cultures and makes the information more easily understood by patients whose drug use and mental states have resulted in reduced cognitive abilities.
Is training necessary to implement the Hazelden Co-occurring Disorders Program?
Implementation training developed by Hazelden with faculty of the Dartmouth Psychiatric Research Center to help addiction treatment and mental health centers develop greater capacity, skills, and processes to treat non-severe mental health patients with substance use disorders is available.
Fidelity of implementation of the Hazelden Co-occurring Disorders Program is vital to attaining effective outcomes. It is recommended that you and/or your facility receive additional training and support from Hazelden Publishing and the Dartmouth Psychiatric Research Center to ensure efficacy of the model.
Learn more about training. Customers may also contact Hazelden Publishing at 800-328-9000.